DuPont locks in $455M North Carolina PFAS settlement; liability was partly reserved

The direction was already visible before this filing. DuPont had disclosed a $125 million accrual for the North Carolina matters as of June 30, 2026, while settlement discussions were ongoing. That makes the settlement partly known rather than a surprise; the new information is the final structure and $455 million aggregate amount, not the existence of a liability.

The filing formalizes a large, long-dated obligation across three companies. Total settlement payments are $455 million over 15 years, beginning within 30 days of execution. (Settlement announcement)

The $455 million headline is not the same as a new $455 million DuPont charge. It is the combined obligation of DuPont, Chemours and Corteva, paid over time, while the prior $125 million figure was DuPont’s already-recorded accrual. The filing does not state DuPont’s final standalone cash share or identify a new incremental income-statement charge, so the settlement cannot be treated as a clean earnings miss versus the prior reserve.

Escrow relief is the main offset. The companies’ aggregate New Jersey and North Carolina payments will satisfy required future MOU escrow contributions, including the contribution otherwise due in September 2026. (MOU understandings) 〔0〕 That improves near-term funding mechanics, but it is a funding offset rather than a cancellation of the underlying liability.

Net: a mixed resolution, not a clear financial beat or miss. DuPont removes uncertainty around the covered North Carolina state and local claims, but confirms a substantial obligation and does not quantify the company’s ultimate standalone payment or all remaining PFAS exposure. The covered dismissals still need to be entered, making this a partly anticipated settlement with meaningful closure but no clean positive surprise.